Biotechnology News and Research

RSS
Prestigious Janssen Industry Excellence Awards announced

Prestigious Janssen Industry Excellence Awards announced

Prana's PBT2 effective in reversing memory, learning losses associated with aging process

Prana's PBT2 effective in reversing memory, learning losses associated with aging process

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

CytoDyn submits protocol to FDA for Phase IIb clinical trial of PRO 140

CytoDyn submits protocol to FDA for Phase IIb clinical trial of PRO 140

Safe sleep environment can reduce risk of Sudden Infant Death Syndrome

Safe sleep environment can reduce risk of Sudden Infant Death Syndrome

Immune Design closes Series C financing totalling up to $49M

Immune Design closes Series C financing totalling up to $49M

Cvrx closes additional $12 million under its Series F financing

Cvrx closes additional $12 million under its Series F financing

ETPN organizes Nanomedicine Award to honor the best international innovation for 2013

ETPN organizes Nanomedicine Award to honor the best international innovation for 2013

Sanovas receives patent for Multi-Balloon Catheter for Extravasated Drug Delivery

Sanovas receives patent for Multi-Balloon Catheter for Extravasated Drug Delivery

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Biogen Idec Q3 total revenues increase 32% to $1.8 billion

Biogen Idec Q3 total revenues increase 32% to $1.8 billion

Biodesix presents additional VeriStrat Phase III trial data at World Conference on Lung Cancer

Biodesix presents additional VeriStrat Phase III trial data at World Conference on Lung Cancer

Scientists work hard to improve procedures for artificially producing tissue

Scientists work hard to improve procedures for artificially producing tissue

ICON Q3 net revenues increase 19% to $339.8 million

ICON Q3 net revenues increase 19% to $339.8 million

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.